197 related articles for article (PubMed ID: 23209329)
1. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
Mueller M; Maldonado-Adrian C; Yuan J; McCann UD; Ricaurte GA
J Pharmacol Exp Ther; 2013 Feb; 344(2):479-88. PubMed ID: 23209329
[TBL] [Abstract][Full Text] [Related]
2. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
Mueller M; Yuan J; Felim A; Neudörffer A; Peters FT; Maurer HH; McCann UD; Largeron M; Ricaurte GA
Drug Metab Dispos; 2009 Oct; 37(10):2079-86. PubMed ID: 19628751
[TBL] [Abstract][Full Text] [Related]
3. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.
Baumann MH; Wang X; Rothman RB
Psychopharmacology (Berl); 2007 Jan; 189(4):407-24. PubMed ID: 16541247
[TBL] [Abstract][Full Text] [Related]
4. Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity.
Escubedo E; Abad S; Torres I; Camarasa J; Pubill D
Neurochem Int; 2011 Jan; 58(1):92-101. PubMed ID: 21074589
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.
Jones DC; Duvauchelle C; Ikegami A; Olsen CM; Lau SS; de la Torre R; Monks TJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):422-31. PubMed ID: 15634943
[TBL] [Abstract][Full Text] [Related]
6. Brain concentrations of d-MDMA are increased after stress.
Johnson EA; O'Callaghan JP; Miller DB
Psychopharmacology (Berl); 2004 May; 173(3-4):278-86. PubMed ID: 14735292
[TBL] [Abstract][Full Text] [Related]
7. On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats.
Goñi-Allo B; Puerta E; Mathúna BO; Hervias I; Lasheras B; de la Torre R; Aguirre N
Neuropharmacology; 2008 Apr; 54(5):885-900. PubMed ID: 18329670
[TBL] [Abstract][Full Text] [Related]
8. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre-treatment against 3,4-methylenedioxymethamphetamine toxicity in rat brain.
Escobedo I; Peraile I; Orio L; Colado MI; O'Shea E
J Neurochem; 2007 Jun; 101(5):1272-83. PubMed ID: 17328712
[TBL] [Abstract][Full Text] [Related]
10. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.
Chu T; Kumagai Y; DiStefano EW; Cho AK
Biochem Pharmacol; 1996 Mar; 51(6):789-96. PubMed ID: 8602874
[TBL] [Abstract][Full Text] [Related]
11. (±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice.
Scheidweiler KB; Ladenheim B; Barnes AJ; Cadet JL; Huestis MA
J Anal Toxicol; 2011 Sep; 35(7):470-80. PubMed ID: 21871156
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity.
Cholanians AB; Phan AV; Lau SS; Monks TJ
Toxicol Sci; 2019 Jul; 170(1):157-166. PubMed ID: 30923810
[TBL] [Abstract][Full Text] [Related]
13. Glial cell response to 3,4-(+/-)-methylenedioxymethamphetamine and its metabolites.
Herndon JM; Cholanians AB; Lau SS; Monks TJ
Toxicol Sci; 2014 Mar; 138(1):130-8. PubMed ID: 24299738
[TBL] [Abstract][Full Text] [Related]
14. Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.
Mueller M; Yuan J; McCann UD; Hatzidimitriou G; Ricaurte GA
Int J Neuropsychopharmacol; 2013 May; 16(4):791-801. PubMed ID: 22824226
[TBL] [Abstract][Full Text] [Related]
15. Aged rats are more vulnerable than adolescents to "ecstasy"-induced toxicity.
Feio-Azevedo R; Costa VM; Barbosa DJ; Teixeira-Gomes A; Pita I; Gomes S; Pereira FC; Duarte-Araújo M; Duarte JA; Marques F; Fernandes E; Bastos ML; Carvalho F; Capela JP
Arch Toxicol; 2018 Jul; 92(7):2275-2295. PubMed ID: 29869127
[TBL] [Abstract][Full Text] [Related]
16. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
Hervías I; Lasheras B; Aguirre N
J Neurochem; 2000 Sep; 75(3):982-90. PubMed ID: 10936179
[TBL] [Abstract][Full Text] [Related]
17. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
Izco M; Orio L; O'Shea E; Colado MI
Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
[TBL] [Abstract][Full Text] [Related]
18. The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity.
Goni-Allo B; O Mathúna B; Segura M; Puerta E; Lasheras B; de la Torre R; Aguirre N
Psychopharmacology (Berl); 2008 Apr; 197(2):263-78. PubMed ID: 18074122
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS
Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680
[TBL] [Abstract][Full Text] [Related]
20. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
